18-20 June 2019 | SNIEC, Shanghai, China |
|
What is Driving the Growth of China' s Pharma Market? |
|
- The Chinese pharma market is forecasted to grow at CAGR of 9.2% between 2018 and 2022, reaching RMB 1,472 billion by 2022.
- Multinational companies continue to expand R&D operations in China. China' s relatively lower cost base compared to developed markets globally is one of the attractions for these companies.
- The 'Made in China 2025' initiative identified biopharma and advanced medicinal products as one of 10 key sectors that the country will focus on.
- China' s large pharmaceutical market and its long growth potential provide and impetus for international pharmaceutical firms to develop medicines specifically for the country' s domestic market.
|
|
Discover China' s Pharma Opportunities |
|
CPhI & P-MEC China is the largest and most comprehensive pharmaceutical event in Asia and covers all aspects of the pharmaceutical supply chain. CPhI & P-MEC China 2019 will take place on 18-20 June 2019 at SNIEC, Shanghai, China, and is expected to gather 3,200+ exhibitors and 50,000 professional visitors from over 120 countries and regions of the world. It is the event to attend to break into this large and growing market! |
|
Your one-shop-store for all Pharma Sectors |
|
|
- Meet all your pharmaceutical sourcing needs under one roof, covering the entire pharma value chain.
- Free matchmaking account helps you pre-arrange meetings as per your business needs.
- Learn from more than 100 onsite conferences and educational sessions.
- Access to the overseas visitor lounge with free refreshments, gift and bottled water onsite.
|
|
|
|
|
|
Explore Further Opportunities in 'China Pharma Week'
|
|
|
|